Personalized prediction of overall survival in patients with AML in non-complete remission undergoing allo-HCT; The transition from quiescent to activated states in human hematopoietic stem cells is governed by dynamic 3D genome reorganization; Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation; Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation.
展开▼
